Clarus Ventures

Latest statistics and disclosures from Clarus Ventures's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Clarus Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Clarus Ventures

Clarus Ventures holds 10 positions in its portfolio as reported in the September 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Avrobio Ord (AVRO) 36.1 $154M 3.0M 51.87
 View chart
Nanostring Technologies (NSTGQ) 16.9 $72M 4.0M 17.83
 View chart
Sientra 15.3 $65M 2.7M 23.88
 View chart
Forty Seven 13.4 $57M 3.8M 14.92
 View chart
Gritstone Oncology Ord (GRTS) 8.6 $37M NEW 2.6M 14.24
 View chart
Entasis Therapeutics Holdings Ord 4.2 $18M NEW 1.6M 10.88
 View chart
Restoration Robotics 2.4 $10M 3.6M 2.90
 View chart
Vbi Vaccines 1.5 $6.5M 2.7M 2.42
 View chart
Essa Pharma (EPIX) 1.2 $5.0M 1.7M 3.00
 View chart
Catabasis Pharmaceuticals 0.4 $1.6M 2.0M 0.80
 View chart

Past Filings by Clarus Ventures

SEC 13F filings are viewable for Clarus Ventures going back to 2013

View all past filings